Our top pick for
HMN Financial Inc is a banks-regional business based in the US. HMN Financial shares (HMNF) are listed on the NASDAQ and all prices are listed in US Dollars. HMN Financial employs 171 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$23.36|
|52-week range||$14.35 - $24.72|
|50-day moving average||$23.38|
|200-day moving average||$21.94|
|Wall St. target price||$27.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$3.23|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-19)||23.36|
|1 month (2021-09-24)||-0.55%|
|3 months (2021-07-26)||4.33%|
|6 months (2021-04-26)||16.28%|
|1 year (2020-10-26)||60.66%|
|2 years (2019-10-25)||12.63%|
|3 years (2018-10-25)||13.12%|
|5 years (2016-10-26)||64.51%|
Valuing HMN Financial stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HMN Financial's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
HMN Financial's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, HMN Financial shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$47.5 million|
|Operating margin TTM||43.2%|
|Gross profit TTM||$41.4 million|
|Return on assets TTM||1.52%|
|Return on equity TTM||13.92%|
|Market capitalisation||$108.5 million|
TTM: trailing 12 months
There are currently 5,718 HMN Financial shares held short by investors – that's known as HMN Financial's "short interest". This figure is 21.3% down from 7,266 last month.
There are a few different ways that this level of interest in shorting HMN Financial shares can be evaluated.
HMN Financial's "short interest ratio" (SIR) is the quantity of HMN Financial shares currently shorted divided by the average quantity of HMN Financial shares traded daily (recently around 2278.0876494024). HMN Financial's SIR currently stands at 2.51. In other words for every 100,000 HMN Financial shares traded daily on the market, roughly 2510 shares are currently held short.
However HMN Financial's short interest can also be evaluated against the total number of HMN Financial shares, or, against the total number of tradable HMN Financial shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HMN Financial's short interest could be expressed as 0% of the outstanding shares (for every 100,000 HMN Financial shares in existence, roughly 0 shares are currently held short) or 0.0015% of the tradable shares (for every 100,000 tradable HMN Financial shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against HMN Financial.
Find out more about how you can short HMN Financial stock.
We're not expecting HMN Financial to pay a dividend over the next 12 months.
HMN Financial's shares were split on a 3:2 basis on 25 May 1998. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your HMN Financial shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for HMN Financial shares which in turn could have impacted HMN Financial's share price.
Over the last 12 months, HMN Financial's shares have ranged in value from as little as $14.35 up to $24.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HMN Financial's is 0.163. This would suggest that HMN Financial's shares are less volatile than average (for this exchange).
HMN Financial, Inc. operates as a bank holding company for Home Federal Savings Bank that provides various retail banking products and services. The company offers various deposit accounts, such as savings, interest bearing checking, non-interest bearing checking, money market, and certificate accounts. Its loan products include single family residential loans; commercial real estate and multi-family mortgage loans; construction loans; consumer loans, such as home equity, automobile, recreational vehicle, mobile home, and lot loans, as well as loans secured by deposit accounts, and other loans for household and personal purposes; and commercial business loans. The company offers financial planning products and services; and invests in mortgage-backed and related securities, the United States government agency obligations, and other permissible investments. It operates through 14 full service branches located in Minnesota, Wisconsin, and Iowa; and one loan production offices located in Sartell, Minnesota. HMN Financial, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.